2018-K ~ Amends the PMP Law to grant access to state epidemiologists with Dept. of Health.
02-07-2018 - Committee voted to recommend the approval of Draft #3 to the Board.
02-21-2018 - Draft #3 approved for filing by the Board.
02-26-2018 - Incorporated in SB 109; prefiled for 2018 Regular Session.
08-01-2018 - Effective date of Act 232 (SB 109).
2018-J ~ Amends the pharmacist licensure requirements in the Pharmacy Practice Act.
02-07-2018 - Committee voted to recommend the approval of Draft #1 to the Board.
02-21-2018 - Draft #1 approved for filing by the Board.
02-27-2018 - Incorporated in SB 131; prefiled for 2018 Regular Session.
08-01-2018 - Effective date of Act 31 (SB 131).
2018-H ~ Amends the statutory definition of "drugs of concern" in the Prescription Monitoring Program (PMP) to facilitate the reporting of prescriptions for naloxone.
02-07-2018 - Committee reviewed Draft #1 and requested a minor amendment, then voted to recommend the approval of Draft #2 to the Board.
02-21-2018 - Draft #2 approved for filing by the Board.
02-26-2018 - Incorporated in SB 110; prefiled for 2018 Regular Session.
08-01-2018 - Effective date of Act 146 (SB 110).
2018-G ~ Amends the Prescription Monitoring Program (PMP) Law to change the reporting frequency for dispensers of controlled substances and drugs of concern.
02-07-2018 - Committee voted to defer action on Draft #1 until a later date.
2018-F ~ Amends the Prescription Monitoring Program (PMP) Law to authorize designated representatives of the Medicaid program to access audit trail information for providers caring for Medicaid recipients.
02-07-2018 - Committee voted to recommend the approval of Draft #3 to the Board.
02-21-2018 - Board declined to approve Draft #3 for filing by the Board.
2018-E ~ Amends the Controlled Substances Law to permit the partial filling of prescriptions for all medications listed in Schedule II, consistent with federal legislation adopted in 2016.
02-07-2018 - Committee voted to recommend the approval of Draft #1 to the Board.
02-21-2018 - Draft #1 approved for filing by the Board.
02-27-2018 - Incorporated in SB 134; prefiled for 2018 Regular Session.
08-01-2018 - Effective date of Act 32 (SB 134).
2018-D ~ Amends the Pharmacy Practice Act to allow the Board to waive the license renewal fee for spouses of pharmacists or technicians serving in active duty military.
11-15-2017 - Draft #1 approved for filing by the Board.
02-26-2018 - Incorporated in HB 150: prefiled for 2018 Regular Session.
08-01-2018 - Effective date of Act 63 (HB 150).
2018-C ~ Amends the statutory definition of "approved college of pharmacy" in the Pharmacy Practice Act to remove a specifically titled reference book of foreign pharmacy schools.
02-07-2018 - Committee voted to recommend the approval of Draft #1 to the Board.
02-21-2018 - Draft #1 approved for filing by the Board.
02-26-2018 - Incorporated in HB 151; prefiled for 2018 Regular Session.
08-01-2018 - Effective date of Act 64 (HB 151).
2018-B ~ Amends the Controlled Substances Law to define 'third-party logistics provider', identify such an entity as one of the entities requiring a Controlled Dangerous Substance (CDS) license to transact business with controlled substances, and to set the fee for CDS licenss issued to such entities.
09-28-2017 - Committee voted to recommend the approval of Draft #1 to the Board.
11-15-2017 - Draft #1 approved for filing by the Board.
01-31-2018 - Incorporated in HB 45; prefiled for 2018 Regular Session.
08-01-2018 - Effective date of Act 186 (HB 45).
2018-A ~ Amends the Controlled Substances Law to add additional substances to Schedule I and removes a substance from Schedule II, consistent with DEA scheduling actions since the last state legislative session.
02-07-2018 - Committee voted to recommend the approval of Draft #1 to the Board.
02-21-2018 - Draft #1 approved for filing by the Board.
01-31-2018 - Incorporated in HB 153; prefiled for 2018 Regular Session.
08-01-2018 - Effective date of Act 119 (HB 153).
02-07-2018 - Committee voted to recommend the approval of Draft #3 to the Board.
02-21-2018 - Draft #3 approved for filing by the Board.
02-26-2018 - Incorporated in SB 109; prefiled for 2018 Regular Session.
08-01-2018 - Effective date of Act 232 (SB 109).
2018-J ~ Amends the pharmacist licensure requirements in the Pharmacy Practice Act.
02-07-2018 - Committee voted to recommend the approval of Draft #1 to the Board.
02-21-2018 - Draft #1 approved for filing by the Board.
02-27-2018 - Incorporated in SB 131; prefiled for 2018 Regular Session.
08-01-2018 - Effective date of Act 31 (SB 131).
2018-H ~ Amends the statutory definition of "drugs of concern" in the Prescription Monitoring Program (PMP) to facilitate the reporting of prescriptions for naloxone.
02-07-2018 - Committee reviewed Draft #1 and requested a minor amendment, then voted to recommend the approval of Draft #2 to the Board.
02-21-2018 - Draft #2 approved for filing by the Board.
02-26-2018 - Incorporated in SB 110; prefiled for 2018 Regular Session.
08-01-2018 - Effective date of Act 146 (SB 110).
2018-G ~ Amends the Prescription Monitoring Program (PMP) Law to change the reporting frequency for dispensers of controlled substances and drugs of concern.
02-07-2018 - Committee voted to defer action on Draft #1 until a later date.
2018-F ~ Amends the Prescription Monitoring Program (PMP) Law to authorize designated representatives of the Medicaid program to access audit trail information for providers caring for Medicaid recipients.
02-07-2018 - Committee voted to recommend the approval of Draft #3 to the Board.
02-21-2018 - Board declined to approve Draft #3 for filing by the Board.
2018-E ~ Amends the Controlled Substances Law to permit the partial filling of prescriptions for all medications listed in Schedule II, consistent with federal legislation adopted in 2016.
02-07-2018 - Committee voted to recommend the approval of Draft #1 to the Board.
02-21-2018 - Draft #1 approved for filing by the Board.
02-27-2018 - Incorporated in SB 134; prefiled for 2018 Regular Session.
08-01-2018 - Effective date of Act 32 (SB 134).
2018-D ~ Amends the Pharmacy Practice Act to allow the Board to waive the license renewal fee for spouses of pharmacists or technicians serving in active duty military.
11-15-2017 - Draft #1 approved for filing by the Board.
02-26-2018 - Incorporated in HB 150: prefiled for 2018 Regular Session.
08-01-2018 - Effective date of Act 63 (HB 150).
2018-C ~ Amends the statutory definition of "approved college of pharmacy" in the Pharmacy Practice Act to remove a specifically titled reference book of foreign pharmacy schools.
02-07-2018 - Committee voted to recommend the approval of Draft #1 to the Board.
02-21-2018 - Draft #1 approved for filing by the Board.
02-26-2018 - Incorporated in HB 151; prefiled for 2018 Regular Session.
08-01-2018 - Effective date of Act 64 (HB 151).
2018-B ~ Amends the Controlled Substances Law to define 'third-party logistics provider', identify such an entity as one of the entities requiring a Controlled Dangerous Substance (CDS) license to transact business with controlled substances, and to set the fee for CDS licenss issued to such entities.
09-28-2017 - Committee voted to recommend the approval of Draft #1 to the Board.
11-15-2017 - Draft #1 approved for filing by the Board.
01-31-2018 - Incorporated in HB 45; prefiled for 2018 Regular Session.
08-01-2018 - Effective date of Act 186 (HB 45).
2018-A ~ Amends the Controlled Substances Law to add additional substances to Schedule I and removes a substance from Schedule II, consistent with DEA scheduling actions since the last state legislative session.
02-07-2018 - Committee voted to recommend the approval of Draft #1 to the Board.
02-21-2018 - Draft #1 approved for filing by the Board.
01-31-2018 - Incorporated in HB 153; prefiled for 2018 Regular Session.
08-01-2018 - Effective date of Act 119 (HB 153).
No comments:
Post a Comment